Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
January 18, 2021
Oslo Cancer Cluster

Dehns acquires Norwegian office

Dehns acquires Norwegian office

Dr Deborah Owen, Partner, Dehns. Photo: Dehns

Dr Deborah Owens, Partner, Dehns, is looking forward to help Norwegian companies in the cancer field. Photo: Dehns

Our member Dehns announced this week that the company will set up a local office in Oslo.

The law firm Dehns has acquired the Norwegian Intellectual Property consultancy firm Leogriff. This means Dehns will now have an active Norwegian presence with a local office in Oslo.

Dehns is a law firm specialized in patents and trademarks. Dehns’ attorneys have insight in many different technologies in the engineering, chemistry and biotechnology sectors.

With this acquisition, Dehns gains the highly-experienced Leogriff team with all their additional competencies, skills and expertise in Intellectual Property. Leogriff’s clients include companies, investors, research institutes and universities.

What does this mean for Norwegian companies in cancer innovation and life science?

“Companies in the cancer field and life science sector face many challenges and need an excellent network of advisors to navigate these successfully.”
Dr Deborah Owen, Partner, Dehns.

“Intellectual Property (IP) issues are key to such companies at all stages, and we are delighted that the opening of the Dehns’ Norwegian office provides an expansion of the Dehns’ team to provide even greater experience and expertise in areas relating to IP management and strategy consultancy, which will be of real benefit to Norwegian companies of all sizes in these sectors,” continued Owen.

Dehns was founded in 1920 and is one of Europe’s leading firms of patent and trademark attorneys. The company has more than 230 staff across 8 offices: London, Munich, Oxford, Brighton, Manchester, Bristol, Sandwich and, now, Oslo.

Dr Adrian Samuels, Partner, Dehns. Photo: Dehns

Dr Adrian Samuels, Partner, Dehns. Photo: Dehns

“We are delighted that, having been working closely with Norwegian innovators and industry leaders for over half a century, Dehns’ ongoing success will be supported by this direct investment in Norway.”
Adrian Samuels, Partner, Dehns.

Last updated:
January 18, 2021

Oslo Cancer Cluster

Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines. We are a national non-profit member organisation with about 90 members.

Click here to read more about us!
Get in touch with us!
Visit us

Oslo Cancer Cluster
Ullernchausséen 64
0379 Oslo

Send us mail
Dr Deborah Owen, Partner, Dehns. Photo: Dehns

Dr Deborah Owens, Partner, Dehns, is looking forward to help Norwegian companies in the cancer field. Photo: Dehns

Our member Dehns announced this week that the company will set up a local office in Oslo.

The law firm Dehns has acquired the Norwegian Intellectual Property consultancy firm Leogriff. This means Dehns will now have an active Norwegian presence with a local office in Oslo.

Dehns is a law firm specialized in patents and trademarks. Dehns’ attorneys have insight in many different technologies in the engineering, chemistry and biotechnology sectors.

With this acquisition, Dehns gains the highly-experienced Leogriff team with all their additional competencies, skills and expertise in Intellectual Property. Leogriff’s clients include companies, investors, research institutes and universities.

What does this mean for Norwegian companies in cancer innovation and life science?

“Companies in the cancer field and life science sector face many challenges and need an excellent network of advisors to navigate these successfully.”
Dr Deborah Owen, Partner, Dehns.

“Intellectual Property (IP) issues are key to such companies at all stages, and we are delighted that the opening of the Dehns’ Norwegian office provides an expansion of the Dehns’ team to provide even greater experience and expertise in areas relating to IP management and strategy consultancy, which will be of real benefit to Norwegian companies of all sizes in these sectors,” continued Owen.

Dehns was founded in 1920 and is one of Europe’s leading firms of patent and trademark attorneys. The company has more than 230 staff across 8 offices: London, Munich, Oxford, Brighton, Manchester, Bristol, Sandwich and, now, Oslo.

Dr Adrian Samuels, Partner, Dehns. Photo: Dehns

Dr Adrian Samuels, Partner, Dehns. Photo: Dehns

“We are delighted that, having been working closely with Norwegian innovators and industry leaders for over half a century, Dehns’ ongoing success will be supported by this direct investment in Norway.”
Adrian Samuels, Partner, Dehns.

Last updated:
January 18, 2021

Oslo Cancer Cluster

Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines. We are a national non-profit member organisation with about 90 members.

Click here to read more about us!
Get in touch with us!
Visit us

Oslo Cancer Cluster
Ullernchausséen 64
0379 Oslo

Send us mail